2.9105
전일 마감가:
$2.91
열려 있는:
$2.91
하루 거래량:
555
Relative Volume:
0.00
시가총액:
$5.35M
수익:
$12.31M
순이익/손실:
$-5.08M
주가수익비율:
-3.0963
EPS:
-0.94
순현금흐름:
$-5.20M
1주 성능:
+2.12%
1개월 성능:
-9.33%
6개월 성능:
+6.61%
1년 성능:
-23.37%
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
SNOA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SNOA
Sonoma Pharmaceuticals Inc
|
2.91 | 5.35M | 12.31M | -5.08M | -5.20M | -0.94 |
![]()
RGC
Regencell Bioscience Holdings Ltd
|
21.96 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
![]()
ZTS
Zoetis Inc
|
157.53 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.44 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.97 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.98 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
소노마 파머 주식(SNOA)의 최신 뉴스
Global Dental Market Set to Reach USD 19.13 Bn by 2032, Driven by 7.5% CAGR | Coherent Market Insights - newstrail.com
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | SNOA Stock News - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. SEC 10-K Report - TradingView
SONOMA PHARMACEUTICALS Earnings Preview: Recent $SNOA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Dental Market Set to Witness Robust Growth Fueled by Aesthetic - openPR.com
Keloid Treatment Market Exclusive Trends Analysis with Forecast to 2034 - openPR.com
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Hospital Surgical Disinfectants Market Is Booming So Rapidly - openPR.com
Williams-Sonoma, Inc. (NYSE:WSM) Given Consensus Rating of “Hold” by Analysts - Defense World
Scar Treatment Market Is Booming So Rapidly | Merz, Lumenis, Sientra - newstrail.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200-Day Moving Average – Time to Sell? - Defense World
Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - Business Wire
Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer - citybiz
Keloid Treatment Market Development Accelerated by Consumer - openPR.com
Pre-market Movers: KTTA, SXTC, GLMD, TCMD... - RTTNews
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Checking in on Sonoma Pharmaceuticals Inc (SNOA) after recent insiders movement - knoxdaily.com
A Piece Of The Puzzle Missing From Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) 35% Share Price Climb - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Stocks of Sonoma Pharmaceuticals Inc (SNOA) are poised to climb above their peers - Sete News
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Re - GuruFocus
Sonoma Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Financial Analysis: Integra Resources Corp (ITRG)’s Ratios Unveil Key Insights - DWinneX
Metric Deep Dive: Understanding Sonoma Pharmaceuticals Inc (SNOA) Through its Ratios - DWinneX
Analyzing SNOA’s price-to-book ratio for the last quarter - uspostnews.com
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga
Sonoma Pharmaceuticals Inc (SNOA) Stock: A Year of Declines and Increases - investchronicle.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Financial Snapshot: Analyzing Phio Pharmaceuticals Corp (PHIO)’s Key Ratio Metrics - DWinneX
UK Retail Deal Sparks Early Buying Frenzy in Pharma Stock - The Globe and Mail
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket - marketscreener.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Sonoma Pharmaceuticals (SNOA) Expands Reach with UK Product Regi - GuruFocus
Major UK Retail Breakthrough: Sonoma's Natural Acne Treatment to Roll Out Across 1,200 Leading Pharmacies - Stock Titan
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $315.58 - Defense World
North America Scar Treatment Market Deep Research Report with - openPR.com
NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World
Rising Trends of Scar Treatment Market in Worldwide | Top most Key - openPR.com
Analyzing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
SNOA stock touches 52-week low at $1.84 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $1.84 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Survey: DarioHealth (NASDAQ:DRIO) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Delaware passes law designed to stop more Elon Musks from leaving state - Yahoo Finance
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain - Yahoo Finance
Sonoma Pharmaceuticals expands agreement with WellSpring By Investing.com - Investing.com Australia
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):